Besides, CALU expression in IDH mutant glioma seemed to be universally lower than that in IDH wildtype, across different WHO grade, except for lower grade glioma (LGG) in CGGA, which exhibited apparent trends although not significant (Figure 1b and e). The gene discussed is CALU; the disease is central nervous system cancer.